Cargando…

Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers

BACKGROUND: There is heightened interest in how real-world data (RWD) can be used to supplement or replace traditional mechanisms for collecting clinical information. A critical component in evaluating utility of RWD is assessing the validity and reliability of event measurement. Only two studies ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Wherry, Kael, Stromberg, Kurt, Hinnenthal, Jennifer A, Wallenfelsz, Lisa A, El-Chami, Mikhael F, Bockstedt, Lindsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053654/
https://www.ncbi.nlm.nih.gov/pubmed/32184698
http://dx.doi.org/10.2147/POR.S240913
_version_ 1783503079960739840
author Wherry, Kael
Stromberg, Kurt
Hinnenthal, Jennifer A
Wallenfelsz, Lisa A
El-Chami, Mikhael F
Bockstedt, Lindsay
author_facet Wherry, Kael
Stromberg, Kurt
Hinnenthal, Jennifer A
Wallenfelsz, Lisa A
El-Chami, Mikhael F
Bockstedt, Lindsay
author_sort Wherry, Kael
collection PubMed
description BACKGROUND: There is heightened interest in how real-world data (RWD) can be used to supplement or replace traditional mechanisms for collecting clinical information. A critical component in evaluating utility of RWD is assessing the validity and reliability of event measurement. Only two studies have validated Medicare claims with physician-adjudicated data collected in a clinical study and none in the pacemaker patient population. This study compares events identified in physician-adjudicated clinical registry data collected in the Micra Post-Approval Registry (PAR) with events identified via Medicare administrative claims in the Micra Coverage with Evidence (CED) Study. METHODS: Patients who were dually enrolled in the Micra CED and the Micra PAR between March 9, 2017 and December 1, 2017 were included in the validation analysis. All patients intended to be implanted with a Micra device were eligible for participation in the Micra PAR. All Medicare fee-for-service beneficiaries implanted with a Micra device who met the 12-month continuous enrollment criteria were included in the Micra CED. We compared the count of acute (30-day) complications identified in the Medicare claims and the physician-adjudicated PAR data to assess agreement between data sources. RESULTS: There were 230 patients dually enrolled in the Micra CED and Micra PAR studies during the study period. Overall, there were 17 acute events reported in either the Micra CED or the Micra PAR, with 95% agreement in the identification of events and absence of events between studies. Study disagreement between events reported in either study varied: arteriovenous fistula (50%), pulmonary embolism (67%), hemorrhage/hematoma (75%), and deep vein thrombosis (100%). Among physician-adjudicated events, there was no disagreement between the Micra CED and Micra PAR studies in any event type. CONCLUSION: Findings from this study demonstrate high agreement in event identification between Medicare claims data and registries for patients implanted with Micra leadless pacemakers.
format Online
Article
Text
id pubmed-7053654
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70536542020-03-17 Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers Wherry, Kael Stromberg, Kurt Hinnenthal, Jennifer A Wallenfelsz, Lisa A El-Chami, Mikhael F Bockstedt, Lindsay Pragmat Obs Res Original Research BACKGROUND: There is heightened interest in how real-world data (RWD) can be used to supplement or replace traditional mechanisms for collecting clinical information. A critical component in evaluating utility of RWD is assessing the validity and reliability of event measurement. Only two studies have validated Medicare claims with physician-adjudicated data collected in a clinical study and none in the pacemaker patient population. This study compares events identified in physician-adjudicated clinical registry data collected in the Micra Post-Approval Registry (PAR) with events identified via Medicare administrative claims in the Micra Coverage with Evidence (CED) Study. METHODS: Patients who were dually enrolled in the Micra CED and the Micra PAR between March 9, 2017 and December 1, 2017 were included in the validation analysis. All patients intended to be implanted with a Micra device were eligible for participation in the Micra PAR. All Medicare fee-for-service beneficiaries implanted with a Micra device who met the 12-month continuous enrollment criteria were included in the Micra CED. We compared the count of acute (30-day) complications identified in the Medicare claims and the physician-adjudicated PAR data to assess agreement between data sources. RESULTS: There were 230 patients dually enrolled in the Micra CED and Micra PAR studies during the study period. Overall, there were 17 acute events reported in either the Micra CED or the Micra PAR, with 95% agreement in the identification of events and absence of events between studies. Study disagreement between events reported in either study varied: arteriovenous fistula (50%), pulmonary embolism (67%), hemorrhage/hematoma (75%), and deep vein thrombosis (100%). Among physician-adjudicated events, there was no disagreement between the Micra CED and Micra PAR studies in any event type. CONCLUSION: Findings from this study demonstrate high agreement in event identification between Medicare claims data and registries for patients implanted with Micra leadless pacemakers. Dove 2020-02-28 /pmc/articles/PMC7053654/ /pubmed/32184698 http://dx.doi.org/10.2147/POR.S240913 Text en © 2020 Wherry et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wherry, Kael
Stromberg, Kurt
Hinnenthal, Jennifer A
Wallenfelsz, Lisa A
El-Chami, Mikhael F
Bockstedt, Lindsay
Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers
title Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers
title_full Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers
title_fullStr Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers
title_full_unstemmed Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers
title_short Using Medicare Claims to Identify Acute Clinical Events Following Implantation of Leadless Pacemakers
title_sort using medicare claims to identify acute clinical events following implantation of leadless pacemakers
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053654/
https://www.ncbi.nlm.nih.gov/pubmed/32184698
http://dx.doi.org/10.2147/POR.S240913
work_keys_str_mv AT wherrykael usingmedicareclaimstoidentifyacuteclinicaleventsfollowingimplantationofleadlesspacemakers
AT strombergkurt usingmedicareclaimstoidentifyacuteclinicaleventsfollowingimplantationofleadlesspacemakers
AT hinnenthaljennifera usingmedicareclaimstoidentifyacuteclinicaleventsfollowingimplantationofleadlesspacemakers
AT wallenfelszlisaa usingmedicareclaimstoidentifyacuteclinicaleventsfollowingimplantationofleadlesspacemakers
AT elchamimikhaelf usingmedicareclaimstoidentifyacuteclinicaleventsfollowingimplantationofleadlesspacemakers
AT bockstedtlindsay usingmedicareclaimstoidentifyacuteclinicaleventsfollowingimplantationofleadlesspacemakers